GT Biopharma Balance Sheet
GT Biopharma's total assets for Q4 2025 were $8.11M, an increase of 87.60% from the previous quarter. GTBP total liabilities were $2.32M for the fiscal quarter, a 75.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.